Progenity Inc expected to post a loss of 16  cents a share - Earnings Preview

Biora Therapeutics

14/03/2022 20:03

* Progenity Inc  PROG.OQ   PROG.O  is expected to show a
fall in
quarterly revenue when it reports  results on March 16
(estimated). 
    * The San Diego California-based  company is expected to
report  a
98.2% decrease in revenue to $250 thousand from $14.28 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Progenity Inc is
for a
loss of 16 cents per share. For the same quarter last year, the
company reported a loss of $1.53 per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Progenity
Inc is
$3​, above​ its last closing price of $1.18. ​​​

This summary was machine generated March 14 at 20:03 GMT.  All
figures in US dollars  unless otherwise stated